ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS
Аннотация
.
Об авторах
I. V. Peretokina
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
Россия
Россия
L. Yu. Krylova
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
Россия
Россия
O. V. Antonova
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Россия
Россия
M. S. Kholina
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Россия
Россия
D. A. Gryadunov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Россия
Россия
E. Yu. Nosova
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
Россия
Россия
D. V. Zimenkov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Россия
Россия
Для цитирования:
Peretokina I.V., Krylova L.Y., Antonova O.V., Kholina M.S., Gryadunov D.A., Nosova E.Y., Zimenkov D.V. ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS. Инфекция и иммунитет. 2018;8(4):577. https://doi.org/10.15789/2220-7619-2018-4-6.40
For citation:
Peretokina I.V., Krylova L.Y., Antonova O.V., Kholina M.S., Gryadunov D.A., Nosova E.Y., Zimenkov D.V. ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS. Russian Journal of Infection and Immunity. 2018;8(4):577. https://doi.org/10.15789/2220-7619-2018-4-6.40
Просмотров: 89
Послать статью по эл. почте 